This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sean Murphy: Inventor in Pharmaceutical Research
Introduction
Sean Murphy is an inventor based in San Diego, California, whose patent work concerns pharmaceutical compounds and their potential therapeutic uses. He is associated with Takeda Pharmaceutical Company Limited and has 1 patent listed in the information provided.
Latest Patents
Murphy’s patent, “Macrocyclic heterocycle compounds and use thereof,” describes a heterocyclic compound with orexin type 2 receptor agonist activity, or a salt of that compound. The invention identifies potential use in the prevention or treatment of narcolepsy.
Career Highlights
The available information connects Murphy’s invention to Takeda Pharmaceutical Company Limited, a pharmaceutical company. His patent focuses on a receptor-targeting approach with potential relevance to narcolepsy treatment.
Collaborations
Mitsunori Kono and Yusuke Sasaki are identified as Murphy’s coworkers. Their names are associated with the collaborative research context surrounding the patent.
Conclusion
Sean Murphy’s patent reflects pharmaceutical innovation focused on orexin type 2 receptor agonists and their potential application in preventing or treating narcolepsy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile